GBIM — GlobeImmune Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$8.69m
- $6.46m
Annual cashflow statement for GlobeImmune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.7 | -2.01 | 9.48 | -16.3 | -2.77 |
| Depreciation | |||||
| Non-Cash Items | 1.86 | -1.58 | -1.62 | 10.4 | -0.007 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.9 | -10.4 | -4.69 | -4.53 | -4.54 |
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -5.01 | -13.1 | 3.93 | -10.1 | -7.13 |
| Capital Expenditures | -0.133 | -0.109 | -0.012 | -0.294 | -0.036 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | 0.127 | 0.254 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.133 | -0.109 | -0.012 | -0.167 | 0.218 |
| Financing Cash Flow Items | 0 | — | — | -2.63 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.001 | 0.025 | 0.002 | 21.1 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.14 | -13.2 | 3.92 | 10.9 | -6.91 |